Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.
Clin J Am Soc Nephrol
; 17(8): 1139-1149, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35896277
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vascular Diseases
/
Diabetes Mellitus, Type 2
/
Gliclazide
/
Hyperkalemia
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin J Am Soc Nephrol
Journal subject:
NEFROLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Australia
Country of publication:
Estados Unidos